INTUITIVE SURGICAL INC (1ISRG.MI) Fundamental Analysis & Valuation

BIT:1ISRG • US46120E6023

Current stock price

397.85 EUR
-0.15 (-0.04%)
Last:

This 1ISRG.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. 1ISRG.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1ISRG was profitable.
  • 1ISRG had a positive operating cash flow in the past year.
  • Each year in the past 5 years 1ISRG has been profitable.
  • 1ISRG had a positive operating cash flow in each of the past 5 years.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • 1ISRG has a Return On Assets of 13.96%. This is amongst the best in the industry. 1ISRG outperforms 96.72% of its industry peers.
  • 1ISRG has a better Return On Equity (16.02%) than 88.52% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 13.95%, 1ISRG belongs to the top of the industry, outperforming 91.80% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is above the industry average of 9.41%.
  • The 3 year average ROIC (12.43%) for 1ISRG is below the current ROIC(13.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROIC 13.95%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of 1ISRG (28.38%) is better than 100.00% of its industry peers.
  • 1ISRG's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 29.35%, 1ISRG belongs to the top of the industry, outperforming 98.36% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1ISRG has grown nicely.
  • The Gross Margin of 1ISRG (66.00%) is better than 73.77% of its industry peers.
  • In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
Industry RankSector Rank
OM 29.35%
PM (TTM) 28.38%
GM 66%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. 1ISRG.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
  • 1ISRG has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, 1ISRG has more shares outstanding
  • There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • 1ISRG has an Altman-Z score of 38.87. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
  • 1ISRG has a Altman-Z score of 38.87. This is amongst the best in the industry. 1ISRG outperforms 98.36% of its industry peers.
  • 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 38.87
ROIC/WACC1.56
WACC8.95%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 4.87 indicates that 1ISRG has no problem at all paying its short term obligations.
  • 1ISRG has a Current ratio of 4.87. This is amongst the best in the industry. 1ISRG outperforms 95.08% of its industry peers.
  • 1ISRG has a Quick Ratio of 3.96. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
  • 1ISRG's Quick ratio of 3.96 is amongst the best of the industry. 1ISRG outperforms 96.72% of its industry peers.
Industry RankSector Rank
Current Ratio 4.87
Quick Ratio 3.96
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. 1ISRG.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.92% over the past year.
  • Measured over the past years, 1ISRG shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.42% on average per year.
  • 1ISRG shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.51%.
  • The Revenue has been growing by 18.22% on average over the past years. This is quite good.
EPS 1Y (TTM)25.92%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%38.12%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%22.96%

3.2 Future

  • 1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.55% yearly.
  • 1ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.00% yearly.
EPS Next Y14.43%
EPS Next 2Y14.29%
EPS Next 3Y14.44%
EPS Next 5Y13.55%
Revenue Next Year15.78%
Revenue Next 2Y14.84%
Revenue Next 3Y14.6%
Revenue Next 5Y13%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

2

4. 1ISRG.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 48.46, which means the current valuation is very expensive for 1ISRG.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1ISRG is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 26.77, 1ISRG is valued quite expensively.
  • A Price/Forward Earnings ratio of 39.95 indicates a quite expensive valuation of 1ISRG.
  • 1ISRG's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 67.21% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of 1ISRG to the average of the S&P500 Index (21.75), we can say 1ISRG is valued expensively.
Industry RankSector Rank
PE 48.46
Fwd PE 39.95
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 65.57% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as 1ISRG.
Industry RankSector Rank
P/FCF 66.45
EV/EBITDA 42.31
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of 1ISRG may justify a higher PE ratio.
  • 1ISRG's earnings are expected to grow with 14.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.36
PEG (5Y)2.26
EPS Next 2Y14.29%
EPS Next 3Y14.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1ISRG.MI Dividend Analysis

5.1 Amount

  • 1ISRG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1ISRG.MI Fundamentals: All Metrics, Ratios and Statistics

INTUITIVE SURGICAL INC

BIT:1ISRG (4/28/2026, 7:00:00 PM)

397.85

-0.15 (-0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth60.87
Earnings (Last)04-21
Earnings (Next)07-20
Inst Owners88.75%
Inst Owner ChangeN/A
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap141.30B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts79.02
Price Target516.08 (29.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)-3.34%
PT rev (3m)-2.8%
EPS NQ rev (1m)-0.79%
EPS NQ rev (3m)-0.7%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)2.86%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)0.51%
Valuation
Industry RankSector Rank
PE 48.46
Fwd PE 39.95
P/S 16.44
P/FCF 66.45
P/OCF 54.61
P/B 9.28
P/tB 9.49
EV/EBITDA 42.31
EPS(TTM)8.21
EY2.06%
EPS(NY)9.96
Fwd EY2.5%
FCF(TTM)5.99
FCFY1.5%
OCF(TTM)7.29
OCFY1.83%
SpS24.2
BVpS42.85
TBVpS41.92
PEG (NY)3.36
PEG (5Y)2.26
Graham Number88.9676 (-77.64%)
Profitability
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROCE 16.01%
ROIC 13.95%
ROICexc 20.73%
ROICexgc 21.4%
OM 29.35%
PM (TTM) 28.38%
GM 66%
FCFM 24.75%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 79.72%
Cap/Sales 5.36%
Interest Coverage 250
Cash Conversion 83.46%
Profit Quality 87.21%
Current Ratio 4.87
Quick Ratio 3.96
Altman-Z 38.87
F-Score8
WACC8.95%
ROIC/WACC1.56
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)25.92%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%38.12%
EPS Next Y14.43%
EPS Next 2Y14.29%
EPS Next 3Y14.44%
EPS Next 5Y13.55%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%22.96%
Revenue Next Year15.78%
Revenue Next 2Y14.84%
Revenue Next 3Y14.6%
Revenue Next 5Y13%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year35.45%
EBIT Next 3Y21.62%
EBIT Next 5Y17.23%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%

INTUITIVE SURGICAL INC / 1ISRG.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to 1ISRG.MI.


What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.


What is the profitability of 1ISRG stock?

INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 9 / 10.


What is the expected EPS growth for INTUITIVE SURGICAL INC (1ISRG.MI) stock?

The Earnings per Share (EPS) of INTUITIVE SURGICAL INC (1ISRG.MI) is expected to grow by 14.43% in the next year.